Now Available: Diagnostics Year in Review 2023. Click to Download Report.
“While most liquid biopsy efforts focus on circulating tumor DNA (ctDNA), Alamar is taking a different path, looking for circulating cancer-associated protein biomarkers,” said Nick Naclerio, Ph.D., Founding Partner of Illumina Ventures. “This is mostly undiscovered territory and could ultimately lead to highly sensitive diagnostics that find cancer and other diseases early when they are most ...
Stilla Technologies announced on Tuesday it has raised €31.3 million ($35.2 million) in new funding. The Paris-based firm will use the funds to expand its global commercial presence and develop its next-generation digital PCR platform.
Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the completion of an oversubscribed and up-sized $215 million Series B financing. Including this round, the Company has raised over $300 million to date.
DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing led by Coatue Management and Catalio Capital Management. The new funds will be used to accelerate expansion and commercialization of the company’s revolutionary SYNTAX Platform.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
